| sCD163 |
This study aimed to develop a first trimester prediction model for gestational d… |
Serum |
GDM(n=20),Normal Glucose Tolerance(n=185)
|
ELISA |
11th to 13th? gestational weeks |
Weighted Linear Regression |
First trimester biomarkers for prediction of gestational diabetes mellitus |
2020 |
Placenta |
32937245 |
Risk factor |
| Vit B12 |
This study aimed to explore the association between early pregnancy levels of fo… |
Serum |
GDM(n=180),Normal Glucose Tolerance(n=878)
|
Electrochemiluminescence Assays |
9th to 13th gestational weeks |
|
Association of Maternal Folate and Vitamin B12 in Early Pregnancy With Gestational Diabetes Mellitus: A Prospective Cohort Study |
2021 |
Diabetes Care |
33158950 |
Risk factor |
| FhCG-beta |
This study aimed to determine whether maternal serum concentrations of pregnancy… |
Serum |
GDM(n=870),Normal Glucose Tolerance(n=6559)
|
Time-Resolved Amplified Cryptate Emission (TRACE) |
11th to 13th (+6day)? gestational weeks |
|
The association between gestational diabetes mellitus and first trimester aneuploidy screening markers |
2013 |
Annals of Clinical Biochemistry |
23897108 |
Risk factor |
| NAMPT |
Pre-B-cell colony-enhancing factor (PBEF), also known as visfatin, is an adipocy… |
|
|
|
|
|
Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions |
2007 |
J Endocrinol Invest |
17392604 |
Mechanism |
| NAMPT |
This case-control study aimed to evaluate the potential of maternal serum visfat… |
Serum |
GDM(n=100),Normal Glucose Tolerance(n=300)
|
ELISA |
11th to 13th gestational weeks |
|
Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus |
2011 |
Clinical Chemistry |
21325104 |
Risk factor |
| NAMPT |
Adipocytokines, predominantly derived from adipocytes, play a crucial role in re… |
|
|
|
|
|
Visfatin, an adipocytokine with proinflammatory and immunomodulating properties |
2007 |
J Immunol |
17237424 |
Mechanism |
| NAMPT |
This case-case control study aimed to determine whether serum leptin, resistin,… |
Serum |
GDM(n=70),Normal Glucose Tolerance(n=70)
|
ELISA |
11th to 14th gestational weeks |
Logistic Regression |
Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus |
2019 |
Lipids in Health And Disease |
31836012 |
Risk factor |
| t-PA |
Plasminogen activator inhibitor-1 (PAI-1) levels are elevated in metabolic disor… |
|
|
|
|
|
Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects |
1999 |
Am J Med |
10527036 |
Mechanism |
| t-PA |
This study aimed to evaluate the potential of first trimester maternal biomarker… |
Plasma |
GDM(n=16),Normal Glucose Tolerance(n=80)
|
ELISA |
11th to 14th gestational weeks |
Logistic Regression |
First trimester prediction of gestational diabetes mellitus using plasma biomarkers: a case-control study |
2019 |
Journal of Perinatal Medicine |
30205647 |
Risk factor |
| IGF-1 |
Insulin-like growth factor 1 (IGF1) is a key peptide growth factor involved in g… |
|
|
|
|
|
The IGF1 Signaling Pathway: From Basic Concepts to Therapeutic Opportunities |
2023 |
Int J Mol Sci |
37834331 |
Mechanism |